reports
- GlobalData Healthcare Department
Dermira Inc (DERM) - Financial Analysis Review
Dermira Inc (DERM) - Financial Analysis Review Summary Dermira Inc (Dermira) focuses on the development and commercialization of novel therapies for the treatment of dermatologic diseases. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atopic dermatitis and acne. Its pipeline products include cimzia, DRM04 and DRM01. Dermira’s DRM01 is a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity. GlobalData's Dermir...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.